Vadimezan (DMXAA)
Product Specifications
CAS Number
117570-53-3
Synonyms
ASA404, NSC 640488
SKU
C07878-5mg
Target
VDA
Applications
Angiogenesis
Smiles
CC1=C (C2=C (C=C1) C (=O) C3=CC=CC (=C3O2) CC (=O) O) C
Molecular Formula
C17H14O4
Additionnal Information
Vadimezan (DMXAA) is a vascular disrupting agents (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 μM and IC50 of 62.5 μM in cell-free assays, respectively. DMXAA (Vadimezan) is also a STING agonist with potential antineoplastic activity. DMXAA (Vadimezan) potently induces IFN-β but relatively low TNF-α expression in vitro. DMXAA (Vadimezan) has antiviral activity. Phase 3.
Storage Conditions
2 years -80 in solvent
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M1202-65L-ML750 100 µL
MIP3B, NT (C-C Motif Chemokine 19, Small Inducible Cytokine A19, Macrophage Inflammatory Protein 3 beta, MIP-3-beta, Epstein-Barr Virus-induced Molecule 1 Ligand Chemokine, EBI1-ligand Chemokine, ELC, Beta Chemokine Exodus-3, CK beta-11, CCL19, SCYA19) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
GTR15391140 1 Vial
Lentiviral human DDX3Y sgRNA gene knockout kit - Lentiviral human DDX3Y sgRNA gene knockout kit (25)
Sign In for Pricing
View Details 